Idiopathic Pulmonary Fibrosis Registry for Future Studies

Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00815711

Enrollment

Registered

2008-12-30

Start date

2008-12-01

Completion date

2015-06-10

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis, Lung Disease, Interstitial

Keywords

IPF

Brief summary

To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.

Detailed description

To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with physiologic measures that follow patients through their course will allow the following proposed studies as well as future investigations to be efficiently carried out.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* any patient referred to the Interstitial Lund Disease clinic who is undergoing evaluation and or treatment for a new diagnosis of ILD. This can include patients referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP), sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia, drug-induced, or other idiopathic ILDs.

Exclusion criteria

* pregnancy * inability to follow study requirements

Design outcomes

Primary

Measure	Time frame	Description
Framework	7 + years	To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated

Countries

United States

Outcome results